Archive Category: 10X Stocks Archive

HIMS Is Back on the Move

Our health care disruptor Hims & Hers Health (HIMS) is on the move again. Over the past month, the shares are up about 20%, and we’re up 330% since I first recommended them. We’ll get to why the shares are moving in a moment. But first, let’s dig deeper into the returns.

Read More

We’re Off to A Strong Start with NeoVolta

Let’s talk about that new position in NeoVolta (NEOV)! We’ve been in NeoVolta for a little over a week, and we’re already up about 11%. And that’s after the shares sold off aggressively today, dropping about 9%. At one point in the first week, we were already up 30% in the stock. This raises two questions for us:

Read More

As the War Keeps Expanding, So Does the Energy Trade

The war in Iran is showing no signs of slowing down. If anything, it appears to be spreading. This morning, news broke that Iranian drones struck two tankers in Egyptian waters in the Mediterranean. Saudi Arabia has also been drawn into the conflict for the first time, joining U.S. forces in attacking Iranian proxies in Iraq.

Read More

Magnificent Who?

In 10X Stocks, we spend our time in corners of the market most investors have never heard of, let alone considered investing in. That’s by design. Stocks capable of growing into 10-baggers don’t exactly sprout up like weeds. By the time a stock has name recognition, it’s usually too big to generate those kinds of returns, at least within the time frame we’re targeting. That’s why we focus on small-cap stocks.

Read More

Cape Where?

Until a few weeks ago, I’d wager most people had never heard of Cabo Verde. That’s perfectly understandable. The island nation off Africa’s west coast has a population of barely half a million people – roughly the size of Wyoming – and virtually no history as an international soccer power. Then the World Cup happened…

Read More

Sign-up == X1904104

Conquering the Market Starts Here ...

In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!

Watchlist